All Access Fund
All Access Fund 2024

NAVAN Technologies

About NAVAN Technologies

NAVAN Technologies, Inc. leads with a game-changing non-viral delivery platform for genetic engineering in human primary cells. Their NanoStraw technology provides direct access to difficult-to-transfect cells, streamlining processes and eliminating viral-based limitations. Faster, more efficient, and cost-effective, NAVAN is driving rapid progress in cellular engineering.